FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/08/027139 [Registered on: 14/08/2020] Trial Registered Prospectively
Last Modified On: 29/07/2020
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   LEFT VENTRICULAR FAILURE IN PATIENTS OF ACUTE EXACERBATION OF COPD 
Scientific Title of Study   LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN PATIENTS OF ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prachi Bagarhatta 
Designation  Post graduate doctor 
Affiliation  MAULANA AZAD MEDICAL COLLEGE 
Address  Maulana Azad Medical College and associated Lok Nayak Hospital and GIPMER, Bahadur Shah Zafar Marg , New Delhi

New Delhi
DELHI
110002
India 
Phone  8130143634  
Fax    
Email  bagarhattaprachi@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Mradul Kumar Daga  
Designation  Director Professor  
Affiliation  MAULANA AZAD MEDICAL COLLEGE 
Address  Maulana Azad Medical College and associated Lok Nayak Hospital and GIPMER, Bahadur Shah Zafar Marg , New Delhi

New Delhi
DELHI
110002
India 
Phone  9968604273  
Fax    
Email  drmraduldaga@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Prachi Bagarhatta 
Designation  Post graduate doctor 
Affiliation  MAULANA AZAD MEDICAL COLLEGE 
Address  Maulana Azad Medical College and associated Lok Nayak Hospital and GIPMER, Bahadur Shah Zafar Marg , New Delhi

New Delhi
DELHI
110002
India 
Phone  8130143634  
Fax    
Email  bagarhattaprachi@gmail.com  
 
Source of Monetary or Material Support  
Maulana Azad Medical College and Associated Lok Nayak Hospital , Bahadur Shah Zafar Marg, New Delhi 110002 
 
Primary Sponsor  
Name  Maulana Azad Medical College 
Address  Bahadur Shah Zafar Marg, New Delhi , INDIA 110002 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
Dr Mradul Kumar Daga  Maulana Azad Medical College and associated Lok Nayak Hospital , Bahadur Shah Zafar Marg , New delhi INDIA 110002 
Dr P Lali  Maulana Azad Medical College and associated Lok Nayak Hospital , Bahadur Shah Zafar Marg , New delhi INDIA 110002 
Dr S Anuradha   Maulana Azad Medical College and associated Lok Nayak Hospital , Bahadur Shah Zafar Marg , New delhi INDIA 110002 
Dr Vimal Mehta  GB Pant Hospital , New Delhi 110002 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Prachi Bagarhatta  Lok Nayak Hospital   Department of General Medicine Lok Nayak Hospital Bahadur Shah Zafar Marg New Delhi
New Delhi
DELHI 
8130143634

bagarhattaprachi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Maulana Azad Medical College and Associated Lok Nayak , Govind Ballabh Pant Hospital , Guru Nanak Eye Centre, New Delhi   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J441||Chronic obstructive pulmonary disease with (acute) exacerbation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients with age 18 years or more with acute exacerbation of chronic obstructive pulmonary disease and ability to undergo echocardiography 
 
ExclusionCriteria 
Details  Pulmonary embolism
Pneumonia
Pneumothorax
Renal Dysfunction
Acute coronary event
Valvular Heart Disease
Hepatic Dysfunction
Known case of Dilated Cardiomyopathy 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To evaluate the prevalence of ventricular systolic dysfunction in patients of acute exacerbation of chronic obstructive pulmonary disease   Less than or equal to one year 
 
Secondary Outcome  
Outcome  TimePoints 
To determine the correlation between NTproBNP levels and Left ventricular systolic dysfunction in acute exacerbation of COPD  Less than or equal to one year 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   29/08/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Purpose of trial - To evaluate prevalence of left ventricular systolic dysfunction in patients with acute exacerbation of COPD


Objectives -

Primary Objective-To evaluate the prevalence of left ventricular systolic dysfunction in patients with acute exacerbation of COPD

Secondary Objective - To determine correlation between NTpro BNP levels and left ventricular systolic dysfunction in patients with acute exacerbation of COPD 



Some Major findings and references-


In a research study conducted by Winther et al. evaluating the diagnostic and prognostic significance of NT pro BNP in acute exacerbation of COPD and heart failure it was found to be a good marker to separate dyspnoea due to acute heart failure and not due to heart failure.

A study by Chang et al. analysed cardiac biomarkers in predicting mortality in acute exacerbation of COPD 

In a study by Abroug et al. showed 31 % patients admitted in ICU for severe AE COPD had associated left heart dysfunction. NT pro BNP levels performed better to rule out than to rule in AECOPD with left dysfunction.An NT proBNp level of 1000pg/ml or less was the optimal cutoff to rule out an association of LV dysfunction with sensitivity of 94 % negative predictive value 94% and negative likelihood ratio of 0.08. 







 
Close